We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.2B
AUM Growth
-$33.6M
Cap. Flow
+$15.8M
Cap. Flow %
1.32%
Top 10 Hldgs %
22.6%
Holding
147
New
20
Increased
35
Reduced
44
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 94.67%
2 Industrials 4.36%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
76
DELISTED
Exact Sciences
EXAS
$6.46M 0.54%
67,700
+9,200
+16% +$971K
DNLI icon
77
Denali Therapeutics
DNLI
$3.65B
$6.43M 0.53%
127,500
+62,500
+96% +$3.52M
ALHC icon
78
Alignment Healthcare
ALHC
$3.08B
$6.41M 0.53%
401,145
-444,842
-53% -$8.59M
MRNA icon
79
Moderna
MRNA
$21.8B
$6.39M 0.53%
16,605
+3,955
+31% +$1.46M
ASND icon
80
Ascendis Pharma A/S
ASND
$16B
$6.16M 0.51%
38,650
+35,100
+989% +$4.8M
STAA icon
81
STAAR Surgical
STAA
$1.21B
$6.08M 0.51%
47,300
+4,300
+10% +$602K
THC icon
82
Tenet Healthcare
THC
$20.5B
$5.91M 0.49%
89,000
+4,000
+5% +$284K
QTRX icon
83
Quanterix
QTRX
$164M
$5.79M 0.48%
116,186
-18,000
-13% -$928K
SWAV
84
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$5.76M 0.48%
28,000
MRK icon
85
Merck
MRK
$322B
$5.65M 0.47%
75,250
NTRA icon
86
Natera
NTRA
$38.3B
$5.55M 0.46%
49,850
BIIB icon
87
Biogen
BIIB
$30B
$5.5M 0.46%
19,432
BSX icon
88
Boston Scientific
BSX
$69.5B
$5.47M 0.45%
125,976
+10,000
+9% +$442K
NEO icon
89
NeoGenomics
NEO
$1.96B
$5.43M 0.45%
+112,500
New +$5.21M
STVN icon
90
Stevanato
STVN
$5.42B
$5.38M 0.45%
+212,713
New +$5.01M
PFE icon
91
Pfizer
PFE
$143B
$5.2M 0.43%
120,900
-72,500
-37% -$3.21M
DHR icon
92
Danaher
DHR
$137B
$5.11M 0.42%
18,922
MDT icon
93
Medtronic
MDT
$109B
$5.04M 0.42%
40,201
-36,900
-48% -$4.78M
DCPH
94
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.81M 0.4%
+141,500
New +$4.52M
BTTX
95
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$4.65M 0.39%
+466,200
New +$4.64M
PGNY icon
96
Progyny
PGNY
$2.44B
$4.49M 0.37%
+80,100
New +$4.42M
BMY icon
97
Bristol-Myers Squibb
BMY
$133B
$4.32M 0.36%
73,074
-52,500
-42% -$3.46M
AXNX
98
DELISTED
Axonics, Inc. Common Stock
AXNX
$3.58M 0.3%
55,000
-313,650
-85% -$21.4M
BYSI icon
99
BeyondSpring
BYSI
$47.3M
$3.42M 0.28%
+217,250
New +$3.9M
ONCR
100
DELISTED
Oncorus, Inc.
ONCR
$3.38M 0.28%
361,821
+26,821
+8% +$306K

Similar funds

Sectoral Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sectoral Asset Management held 147 positions worth $1.2B, down 2.7% from $1.24B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sectoral Asset Management's Q3 2021 filing shows 20 new, 35 increased, 44 reduced and 20 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M. The largest sale was Teleflex, an estimated $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.

  • Sectoral Asset Management's largest Q3 2021 buy was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M.
  • Sectoral Asset Management added most to Treace Medical Concepts in Q3 2021, an estimated $8.26M increase.
  • Sectoral Asset Management's biggest Q3 2021 reduction was Teleflex, cutting an estimated $21.8M.
  • Sectoral Asset Management fully exited Oak Street Health, Inc. in Q3 2021, selling an estimated $18.8M.
  • Sectoral Asset Management's ten largest holdings make up 23% of its $1.2B portfolio in Q3 2021.
  • Sectoral Asset Management opened 20 new positions and closed 20 in Q3 2021.
  • Sectoral Asset Management's portfolio value fell 2.7% quarter-over-quarter to $1.2B.

Based on Sectoral Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.